Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;49(8):7567-7573.
doi: 10.1007/s11033-022-07567-y. Epub 2022 Jun 17.

NTRK2 gene fusions are uncommon in pilocytic astrocytoma

Affiliations

NTRK2 gene fusions are uncommon in pilocytic astrocytoma

Daniel Antunes Moreno et al. Mol Biol Rep. 2022 Aug.

Abstract

Background: Pilocytic astrocytoma is the most frequent pediatric glioma. Despite its overall good prognosis, complete surgical resection is sometimes unfeasible, especially for patients with deep-seated tumors. For these patients, the identification of targetable genetic alterations such as NTRK fusions, raised as a new hope for therapy. The presence of gene fusions involving NTRK2 has been rarely reported in pilocytic astrocytoma. The aim of the present study was to investigate the frequency of NTRK2 alterations in a series of Brazilian pilocytic astrocytomas.

Methods: Sixty-nine pilocytic astrocytomas, previously characterized for BRAF and FGFR1 alterations were evaluated. The analysis of NTRK2 alterations was performed using a dual color break apart fluorescence in situ hybridization (FISH) assay.

Results: NTRK2 fusions were successfully evaluated by FISH in 62 of the 69 cases. Neither evidence of NTRK2 gene rearrangements nor NTRK2 copy number alterations were found.

Conclusions: NTRK2 alterations are uncommon genetic events in pilocytic astrocytomas, regardless of patients' clinicopathological and molecular features.

Keywords: FISH.; Gene fusions; NTRK2; Pilocytic astrocytoma; Tyrosine kinases.

PubMed Disclaimer

References

    1. Ostrom QT, Patil N, Cioffi G et al (2020) CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2013–2017. Neurooncology 22:IV1–IV96. https://doi.org/10.1093/neuonc/noaa200 - DOI
    1. National Cancer Institute José Alencar Gomes da Silva (INCA) (2013) Cancer in Brazil - Data from the Population Based Registries. In: ISBN 978-85-7318-221-7. https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/ca... . Accessed 6 Dec 2021
    1. Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 131:803–820. https://doi.org/10.1007/s00401-016-1545-1 - DOI - PubMed
    1. Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Ellison DA D (2021) The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol 23:1231–1251. https://doi.org/10.1093/NEUONC/NOAB106 - DOI - PubMed - PMC
    1. Collins KL, Pollack IF (2020) Pediatric low-grade gliomas. Cancers (Basel) 12

Substances

LinkOut - more resources